Immunoglobulin A1 protease: A new therapeutic candidate for immunoglobulin A nephropathy

Nephrology

Volumn 15, Issue 5, 2010, Pages 584-586

  Xie, Lin Shen ^a,b   Huang, Jun ^b   Qin, Wei ^b   Fan, Jun Ming ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

immunoglobulin A nephropathy; immunoglobulin A1 protease; therapy

Indexed keywords

IMMUNOGLOBULIN A1 PROTEINASE; PROTEINASE; UNCLASSIFIED DRUG; IGA-SPECIFIC SERINE ENDOPEPTIDASE; IMMUNOGLOBULIN A; PROTEINASE INHIBITOR; SERINE PROTEINASE;

ARTICLE; DRUG DELIVERY SYSTEM; ENZYME SPECIFICITY; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY INJURY; MESANGIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; DRUG EFFECTS; ENZYMOLOGY; GLOMERULONEPHRITIS, IGA; IMMUNOLOGY; METABOLISM;

GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES;

EID: 77955077273     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01278.x     Document Type: Article

References (34)

1. Berthoux FC, Mohey H, Afiani A. Natural history of primary IgA nephropathy. Semin. Nephrol. 2008 28 : 4 9.
2. Radford MG Jr., Donadio JV Jr., Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J. Am. Soc. Nephrol. 1997 8 : 199 207.
3. Rychlik I, Andrassy K, Waldherr R et al. Clinical features and natural history of IgA nephropathy. Ann. Med. Interne (Paris) 1999 150 : 117 126.
4. Smith AC, Feehally J. New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy. Springer Semin. Immunopathol. 2003 24 : 477 493.
5. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987 64 : 709 727.
6. Barratt J, Feehally J. IgA nephropathy. J. Am. Soc. Nephrol. 2005 16 : 2088 2097.
7. Tomino Y. Pathogenesis of IgA nephropathy. Contrib. Nephrol. 2007 157 : 1 7.
8. Lai KN. Future directions in the treatment of IgA nephropathy. Nephron 2002 92 : 263 270.
9. Sebekova K, Dammrich J, Fierlbeck W, Krivosikova Z, Paczek L, Heidland A. Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension. Am. J. Nephrol. 1998 18 : 570 576.
10. Sebekova K, Dammrich J, Krivosikova Z, Heidland A. The effect of oral protease administration in the rat remnant kidney model. Res. Exp. Med. (Berl). 1999 199 : 177 188.
11. Loomes LM, Senior BW, Kerr MA. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect. Immun. 1990 58 : 1979 1985.
12. Nakazawa M, Emancipator SN, Lamm ME. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J. Exp. Med. 1986 164 : 1973 1987. (Pubitemid 17217977)
13. Nakazawa M, Emancipator SN, Lamm ME. Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes. Lab. Invest. 1986 55 : 551 556.
14. Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy. J. Clin. Invest. 1990 86 : 715 722.
15. White RB, Lowrie L, Stork JE, Iskandar SS, Lamm ME, Emancipator SN. Targeted enzyme therapy of experimental glomerulonephritis in rats. J. Clin. Invest. 1991 87 : 1819 1827.
16. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: Critical evaluation of experimental evidence. Apmis 1996 104 : 321 338.
17. Mistry D, Stockley RA. IgA1 protease. Int. J. Biochem. Cell. Biol. 2006 38 : 1244 1248.
18. Yoo EM, Morrison SL. IgA: An immune glycoprotein. Clin. Immunol. 2005 116 : 3 10.
19. van der Boog PJ, van Kooten C, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005 67 : 813 821.
20. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 2004 15 : 622 634.
21. Haakenstad AO, Striker GE, Mannik M. The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology 1982 47 : 407 414.
22. Hebert LA. Disposition of IgA-containing circulating immune complexes. Am. J. Kidney Dis. 1988 12 : 388 392.
23. Mestecky J, Suzuki H, Yanagihara T et al. IgA nephropathy: Current views of immune complex formation. Contrib. Nephrol. 2007 157 : 56 63.
24. Lamm ME, Emancipator SN, Robinson JK et al. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: Potential therapy for IgA nephropathy. Am. J. Pathol. 2008 172 : 31 6.
25. Zhang Z, Zheng Q, Han J et al. The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells. Biomaterials 2009 30 : 1372 1381.
26. Asgeirsdottir SA, Kamps JA, Bakker HI et al. Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Mol. Pharmacol. 2007 72 : 121 131.
27. Asgeirsdottir SA, Zwiers PJ, Morselt HW et al. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am. J. Physiol. Renal. Physiol. 2008 294 : F554 61.
28. Scindia Y, Deshmukh U, Thimmalapura PR, Bagavant H. Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: A novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus. Arthritis Rheum. 2008 58 : 3884 3891.
29. Panke S, Wubbolts MG. Enzyme technology and bioprocess engineering. Curr. Opin. Biotechnol. 2002 13 : 111 116.
30. Chirino AJ, Ary ML, Marshall SA. Minimizing the immunogenicity of protein therapeutics. Drug Discov. Today 2004 9 : 82 90.
31. Chintalacharuvu KR, Chuang PD, Dragoman A et al. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect. Immun. 2003 71 : 2563 2570.
32. Senior BW, Dunlop JI, Batten MR, Kilian M, Woof JM. Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases. Infect. Immun. 2000 68 : 463 469.
33. Batten MR, Senior BW, Kilian M, Woof JM. Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases. Infect. Immun. 2003 71 : 1462 1469.
34. Reinholdt J, Tomana M, Mortensen SB, Kilian M. Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Infect. Immun. 1990 58 : 1186 1194.